ProfileGDS4718 / 201955_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 95% 95% 95% 96% 97% 98% 96% 94% 97% 96% 95% 97% 98% 98% 96% 96% 98% 97% 97% 97% 95% 95% 95% 96% 97% 94% 97% 94% 97% 94% 97% 95% 95% 96% 97% 97% 95% 95% 95% 95% 97% 95% 98% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.612596
GSM549102patient 115, normal, homogenized [OPG study]10.385695
GSM549104patient 119, normal, homogenized [OPG study]10.198995
GSM549108patient 138, normal, homogenized [OPG study]10.314895
GSM549119patient 077, normal, homogenized [OPG study]10.595696
GSM549133patient 032, cancer, homogenized [OPG study]11.119197
GSM549139patient 042, cancer, homogenized [OPG study]11.270698
GSM549099patient 107, normal, homogenized [OPG study]10.438596
GSM549109patient 139, normal, homogenized [OPG study]10.060694
GSM549110patient 046, normal, homogenized [OPG study]10.888797
GSM549114patient 063, normal, homogenized [OPG study]10.78996
GSM549122patient 082, normal, homogenized [OPG study]10.367695
GSM549134patient 033, cancer, homogenized [OPG study]10.830797
GSM549136patient 036, cancer, homogenized [OPG study]11.386898
GSM549140patient 044, cancer, homogenized [OPG study]11.173198
GSM549111patient 047, normal, homogenized [OPG study]10.548796
GSM549113patient 057, normal, homogenized [OPG study]10.639696
GSM549132patient 031, cancer, homogenized [OPG study]11.099798
GSM549137patient 038, cancer, homogenized [OPG study]10.77197
GSM549142patient 047, cancer, homogenized [OPG study]10.605997
GSM549100patient 110, normal, homogenized [OPG study]10.772797
GSM549107patient 135, normal, homogenized [OPG study]10.427895
GSM549115patient 068, normal, homogenized [OPG study]10.515995
GSM549116patient 072, normal, homogenized [OPG study]10.296295
GSM549120patient 078, normal, homogenized [OPG study]10.787596
GSM549131patient 030, cancer, homogenized [OPG study]10.852697
GSM549118patient 074, normal, homogenized [OPG study]10.14194
GSM549129patient 027, cancer, homogenized [OPG study]10.520997
GSM549123patient 088, normal, homogenized [OPG study]10.148894
GSM549124patient 006, cancer, homogenized [OPG study]10.90997
GSM549126patient 015, cancer, homogenized [OPG study]9.8649794
GSM549128patient 025, cancer, homogenized [OPG study]10.878597
GSM549103patient 117, normal, homogenized [OPG study]10.152695
GSM549117patient 073, normal, homogenized [OPG study]10.413795
GSM549138patient 041, cancer, homogenized [OPG study]10.442296
GSM549141patient 045, cancer, homogenized [OPG study]10.954697
GSM549130patient 028, cancer, homogenized [OPG study]10.546297
GSM549101patient 111, normal, homogenized [OPG study]10.27895
GSM549105patient 128, normal, homogenized [OPG study]10.197795
GSM549106patient 134, normal, homogenized [OPG study]10.478895
GSM549112patient 048, normal, homogenized [OPG study]10.41795
GSM549125patient 011, cancer, homogenized [OPG study]10.847197
GSM549127patient 024, cancer, homogenized [OPG study]10.008695
GSM549135patient 035, cancer, homogenized [OPG study]11.38998